Search results
Author(s):
Federica Piani
,
Lorenzo Annesi
,
Claudio Borghi
Added:
3 weeks ago
Author(s):
Chim C Lang
Added:
3 weeks ago
Prof Chim Lang discusses his upcoming special focus for ECR. The collection will include contributions from Dr Emily Morris, Dr John Wilding, Dr Samira Bell, Dr Bianca Rocca, and Dr Ramzi Ajjan, the collection explores the global burden of obesity, its impact on heart failure and kidney disease, and emerging therapeutic strategies—including the evolving role of GLP-1 receptor agonists.
View more
Author(s):
Shrilla Banerjee
,
Mirvat Alasnag
,
Marta Kałuzna-Oleksy
,
et al
Added:
6 months ago
In this video, Dr Marta Kałużna-Oleksy is joined by Dr Mirvat Alasnag, Dr Shrilla Banerjee and Dr Michal Hawranek to discuss strategies for heart failure management, based on a presentation at the Prevention and Intervention meeting in 2024.The faculty discuss SCAD, MINOCA and holistic approaches to managing these conditions, including lifestyle factors, hypertension and diabetes. They outline…
View more
Author(s):
Simran Singh Parmar
,
Vasantha Muthuppalaniappan
,
Debasish Banerjee
Added:
1 year ago
Author(s):
Maria Lorenza Muiesan
Added:
3 months ago
Author(s):
Yassir Javaid
,
Michel Burnier
,
Mariya Tokmakova
,
et al
Start date:
Jun 25, 2025
Join an expert panel of internationally recognised cardiovascular specialists for a CME-accredited* webinar on the latest strategies in hypertension management for patients with cardiovascular disease. Chaired by Dr Yassir Javaid (Imperial College Healthcare NHS Trust, London, UK), with Prof Michel Burnier (University Hospital of Lausanne, Lausanne, CH) Prof Mariya Tokmakova (Medical University…
View more
Author(s):
Akshyaya Pradhan
,
Richa Tyagi
,
Prachi Sharma
,
et al
Added:
6 months ago
Author(s):
Giacomo Buso
,
Claudia Agabiti-Rosei
,
Matteo Lemoli
,
et al
Added:
1 year ago
Author(s):
William Herrington
Added:
4 weeks ago
ERA 2025 - Findings from a meta-analysis of chronic kidney disease outcomes in patients treated with empagliflozin suggest that people with CKD benefit from the drug irrespective of diabetes of albuminuria status.ProfWilliam Herrington (University of Oxford, Oxford, UK) joins us to discuss outcomes from an individual patient-level data meta-analysis, investigating the impact of diabetes,…
View more
Author(s):
Rhian Touyz
Added:
10 months ago
ESC Congress 2024 — Dr Rhian Touyz (McGill University Health Center, CA) joins us to discuss key highlights from the ESC 2024 guidelines for the management of elevated blood pressure and hypertension.The new guidelines introduce a new systolic blood pressure treatment target range of 120-129 mmHg, placing emphasis on an intensive target treatment as the first step in patient management - only…
View more